Medicare Enrolled

Dr. Jamil Shah, MD

Internal Medicine · Newark, NJ
Low-engagement
150 BERGEN ST, Newark, NJ 07103
5169675157
In practice since 2014 (11 years)
NPI: 1235535436 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shah? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Shah

Dr. Jamil Shah is an internal medicine specialist in Newark, NJ, with 11 years of NPI registration.

Between the years covered by Open Payments, Dr. Shah received a total of $47,270 from 68 pharmaceutical and/or device companies across 462 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Shah is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice $47,270 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$47,270
Total received (2018-2024)
Avg $6,753/year across 7 years
Top 1% in NJ for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
462
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$47,270 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$13,471
2023
$8,599
2022
$6,345
2021
$3,556
2020
$2,248
2019
$5,868
2018
$7,184

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Olympus Corporation of the Americas
$2,298
Medtronic, Inc.
$1,839
Wilson Cook Medical Incorporated
$1,701
Gilead Sciences, Inc.
$1,418
Boston Scientific Corporation
$1,309
ABBVIE INC.
$1,034
Cook Medical LLC
$761
ViiV Healthcare Company
$609
Janssen Biotech, Inc.
$519
Madrigal Pharmaceuticals
$509
Micro-tech Endoscopy USA, Inc.
$369
Phathom Pharmaceuticals, Inc.
$250
Chiesi USA, Inc.
$128
Bayer Healthcare Pharmaceuticals Inc.
$125
Alnylam Pharmaceuticals Inc.
$125
E.R. Squibb & Sons, L.L.C.
$122
Novo Nordisk Inc
$122
FUJIFILM Healthcare Americas Corporation
$101
Takeda Pharmaceuticals U.S.A., Inc.
$51
Ardelyx, Inc.
$34
Braintree Laboratories, Inc.
$26
Intra-Sana Laboratories
$19
Top 3 companies account for 43.3% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$6,085
Boston Scientific Corporation
$4,592
ABBVIE INC.
$3,739
AbbVie Inc.
$3,191
Gilead Sciences, Inc.
$2,784
Olympus Corporation of the Americas
$2,298
Medtronic, Inc.
$2,296
E.R. Squibb & Sons, L.L.C.
$2,100
Wilson Cook Medical Incorporated
$1,872
Novo Nordisk Inc
$1,432
Genentech USA, Inc.
$1,219
Janssen Pharmaceuticals, Inc
$1,119
Lilly USA, LLC
$1,035
Cook Medical LLC
$992
Merck Sharp & Dohme Corporation
$987
Janssen Biotech, Inc.
$824
Alexion Pharmaceuticals, Inc.
$764
ViiV Healthcare Company
$609
Madrigal Pharmaceuticals
$509
Takeda Pharmaceuticals U.S.A., Inc.
$480
AbbVie, Inc.
$478
GlaxoSmithKline, LLC.
$437
Novartis Pharmaceuticals Corporation
$420
AstraZeneca Pharmaceuticals LP
$379
Micro-tech Endoscopy USA, Inc.
$369
Astellas Pharma US Inc
$362
Allergan Inc.
$358
Daiichi Sankyo Inc.
$305
Exelixis Inc.
$255
Incyte Corporation
$250
Phathom Pharmaceuticals, Inc.
$250
SANOFI-AVENTIS U.S. LLC
$250
EISAI INC.
$250
Dova Pharmaceuticals
$245
EMD Serono, Inc.
$242
Bayer HealthCare Pharmaceuticals Inc.
$222
Novocure Inc.
$150
Heron Therapeutics, Inc.
$141
Janssen Scientific Affairs, LLC
$138
Allergan, Inc.
$135
Ferring Pharmaceuticals Inc.
$129
Chiesi USA, Inc.
$128
Bayer Healthcare Pharmaceuticals Inc.
$125
CSL Behring
$125
Dynavax Technologies Corporation
$125
PFIZER INC.
$125
Mylan Specialty L.P.
$125
Intercept Pharmaceuticals, Inc.
$125
Alnylam Pharmaceuticals Inc.
$125
La Jolla Pharmaceutical Company
$125
TESARO, Inc.
$125
Amgen Inc.
$124
Insmed, Inc.
$121
Sunovion Pharmaceuticals Inc.
$119
GENZYME CORPORATION
$118
Celgene Corporation
$118
RedHill Biopharma Inc.
$112
Relypsa, Inc.
$109
Seattle Genetics, Inc.
$101
FUJIFILM Healthcare Americas Corporation
$101
AVEO Pharmaceuticals, Inc.
$94
W. L. Gore & Associates, Inc.
$50
Nestle HealthCare Nutrition Inc.
$47
Ardelyx, Inc.
$34
Braintree Laboratories, Inc.
$26
ERBE USA Inc
$25
Intra-Sana Laboratories
$19
Genentech, Inc.
$10
Top 3 companies account for 30.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · APRETUDE · APTIOM · AVYCAZ · Acquire · Activase · Arikayce · BARRX · BAVENCIO · BLENREP · BRILINTA · Biktarvy · CABENUVA · CINVANTI · CREON · CRESEMBA · Cabometyx · DALVANCE · DIFICID · DISPOSABLE DISTAL ATTACHMENT · DUPIXENT · Descovy · Doptelet · ELEVIEW · ELFABRIO · ELIQUIS · ENDOFLIP · EOHILIA · EXALT Model D · Epclusa · Esbriet · FARXIGA · FOTIVDA · FUJIFILM · FUSION · GATTEX · GAZYVA · GI GENIUS · GIAPREZA · GIVLAARI · GORE CARDIOFORM Septal Occluder · HEMOSPRAY · HUMIRA · Heplisav-B · IBSRELA · INJECTAFER · INTERSTIM · INVOKANA · Instinct · JAKAFI · JARDIANCE · KEYTRUDA · Kcentra · Kerendia · LINZESS · LUMAKRAS · Lenvima · Livdelzi · MAVYRET · MOUNJARO · MYRBETRIQ · Mavyret · NOXAFIL · OCALIVA · OFEV · ONUREG · OPDIVO · Oncology · Ozempic · PRADAXA · PREVNAR - 13 · PREVYMIS · Pomalyst · QULIPTA · REBLOZYL · REBYOTA · RELTONE 200 MG · REMICADE · RESMETIROM · REZDIFFRA · RINVOQ · RYBELSUS · RYDAPT · Resolution 360 Clip · Revlimid · Rybelsus · SHINGRIX · SKYRIZI · SOLIQUA 100/33 · SOLIRIS · SPIRIVA RESPIMAT · STEGLATRO · STELARA · SUTAB · Single Use Electrosurgical Knife KD-655 · SpyGlass · TASIGNA · TEFLARO · TREMFYA · TRULICITY · Talicia · Tresiba · Trodelvy · UBRELVY · ULTOMIRIS · VIBERZI · VIO · VISIGLIDE · VOQUEZNA · VRAYLAR · Veltassa · Vemlidy · Victoza · WallFlex Duodenal · Wegovy · XARELTO · Yupelri · ZEJULA · ZENPEP · ZEPOSIA · ZERBAXA · eyeMAX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for internal medicine in NJ.

Looking for an internal medicine specialist in Newark?
Compare internal medicine physicians in the Newark area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
10,418
Per 100K population
1219.7
County median income
$76,712
Nearest hospital
THE UNIVERSITY HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Shah is an internal medicine specialist, with low-engagement industry engagement in the top 1% of NJ peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Shah receive payments from pharmaceutical companies?
Yes. Dr. Shah received a total of $47,270 from 68 companies across 462 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Shah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Internal Medicine Physicians in Newark
Browse internal medicine physicians in Newark ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NJ
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NJ
Which NJ internal medicine physicians receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →